Rosenblatt Maintains Buy on Synopsys, Raises Price Target to $620

Benzinga Newsdesk www.benzinga.com Positive 67.5%

Neg 0% Neu 0% Pos 67.5%

Rosenblatt analyst Blair Abernethy maintains Synopsys (NASDAQ:SNPS) with a Buy and raises the price target from $575 to $620.